Linezolid Impurity 31 - Request Quote
Linezolid Impurity 31
| SZ CAT No: | SZ-L025054 |
| CAS No | NA |
| Mol.F. | C33H47F2N5O9 |
| Mol.Wt. | 695.8 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linezolid Impurity 31 is chemically N-((3-(3-fluoro-4-morpholinocyclohexyl)-2-oxooxazolidin-5-yl)methyl)-N-(3-(((R)-3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methoxy)-2-hydroxypropyl)acetamide. Linezolid Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Linezolid Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linezolid.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Linezolid Impurity 31
Purchase Linezolid Impurity 31
Linezolid Impurity 31 suppliers
Linezolid Impurity 31 manufacturers
Linezolid Impurity 31 price
Order Linezolid Impurity 31
Enquire Linezolid Impurity 31
Linezolid Impurity 31 cost
Linezolid Impurity 31 Supplier
Linezolid Impurity 31 Distributor
Linezolid Impurity 31 for Method Validation
Linezolid Reference Standard
Linezolid Impurity 31 for ANDA Filing
Linezolid Impurity 31 for Forced Degradation Studies
Linezolid Impurity 31 Identification Standards
Linezolid Impurity 31 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.